Danno Daisuke, Suzuki Shiho, Takizawa Tsubasa, Ishii Ryotaro, Hamakawa Masayuki, Tanizawa Yoshinori, Osaga Satoshi, Komori Mika
Tominaga Hospital, Osaka, Japan.
Dokkyo Medical University, Mibu, Japan.
Neurol Ther. 2025 Feb;14(1):335-356. doi: 10.1007/s40120-024-00690-x. Epub 2024 Dec 21.
The impact of migraine on patients' lives, including challenges they face before getting access to appropriate medical management, is not well understood. The ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE [OVERCOME (Japan)] 2nd study was conducted to provide information regarding burden and experience with migraine throughout the life course.
This cross-sectional, population-based, nationwide online survey was conducted in adults with or without migraine. The migraine group reported their headache features and experiences in medical management since headache onset. Migraine's burden and impact were assessed with various PRO instruments. Migraine and non-migraine groups reported their experiences in life events and answered questions on self-esteem. Subgroup analyses by the number of monthly headache days (MHD) were performed.
The migraine group (n = 19,590) was numerically younger [mean (SD) age 40.5 (13.1) years vs. 53.1 (17.8) years] and included more females (68.8% vs. 52.1%) than the non-migraine group (n = 2219). The migraine group had mean (SD) 3.5 (5.2) MHDs; 24.2-56.7% had moderate-to-very severe disease burden per various PRO instruments. Headaches started when respondents with migraine were 17.8 years old; 86.7% started over-the-counter medications at 19.4 years of age. Only 46.4% self-reported migraine diagnosis by a physician and 25.1% received an oral preventive drug, almost a decade after headache onset. Up to 16.8% reported poor support/lack of understanding from either teachers or parents during school life. The migraine group had numerically more frequent job changes and divorce, and lower self-esteem, than the non-migraine group. Across assessments, increased MHDs tended to worsen outcomes.
Migraine affected many individuals from an early stage, but timely support and medical intervention were insufficient. This may negatively impact important life events, cause long-term impairment, and decrease self-esteem. Hence, improving the social understanding and medical environment for migraine to provide timely support is essential.
偏头痛对患者生活的影响,包括他们在获得适当医疗管理之前所面临的挑战,目前尚未得到充分了解。偏头痛的流行病学、治疗和护理观察性调查[OVERCOME(日本)]第二项研究旨在提供有关偏头痛在整个生命过程中的负担和经历的信息。
这项基于人群的全国性在线横断面调查针对有或没有偏头痛的成年人开展。偏头痛组报告了自头痛发作以来他们的头痛特征及就医经历。使用各种患者报告结局(PRO)工具评估偏头痛的负担和影响。偏头痛组和非偏头痛组报告了他们在生活事件中的经历,并回答了有关自尊的问题。按每月头痛天数(MHD)进行亚组分析。
偏头痛组(n = 19590)在数字上比非偏头痛组(n = 2219)更年轻[平均(标准差)年龄40.5(13.1)岁对53.1(17.8)岁],且女性比例更高(68.8%对52.1%)。偏头痛组的平均(标准差)每月头痛天数为3.5(5.2)天;根据各种PRO工具,24.2% - 56.7%的患者有中度至非常严重的疾病负担。偏头痛患者的头痛始于17.8岁;86.7%的患者在19.4岁时开始使用非处方药。头痛发作近十年后,只有46.4%的患者自述被医生诊断为偏头痛,25.1%的患者接受了口服预防性药物治疗。高达16.8%的患者报告在学校生活中得到老师或家长的支持不佳/缺乏理解。偏头痛组在数字上比非偏头痛组有更频繁的工作变动和离婚情况,且自尊水平更低。在各项评估中,每月头痛天数增加往往会使结果恶化。
偏头痛从早期就影响了许多人,但及时的支持和医疗干预不足。这可能对重要生活事件产生负面影响,导致长期损害,并降低自尊。因此,改善对偏头痛的社会认知和医疗环境以提供及时支持至关重要。